Skip to main content

Select one (1) article from a magazine or newspaper that has

Page 1


Select one (1) article from a magazine or newspaper that has something in it that pertains to biology

Please see below request due by 7:30 AM EST on August 2, 2014. Select one article from a magazine or newspaper that pertains to biology. You will use this as your target article for the assignment. Write a 1-3 page paper that includes a summary of the article in your own words, an explanation of how the article relates to this course and relevant biological concepts, a discussion of why the article caught your attention and its significance to your life, and your opinion on how research on this topic should be funded. The paper should incorporate at least one additional resource besides the target article, and all sources must be cited in APA format. Include a cover page and a reference page, with the main content double-spaced, in Times New Roman size 12 font, with one-inch margins.

Paper For Above instruction

The rapid advancement of biology-related research has far-reaching implications across various sectors, influencing not only scientific communities but also affecting societal, environmental, and personal facets of life. In this paper, I will analyze a recent newspaper article titled "CRISPR Gene Editing: The Future of Medicine," published in The New York Times (Smith, 2022). The article discusses the recent developments in CRISPR-Cas9 technology, a revolutionary gene-editing tool that allows for precise modifications to DNA. It highlights how this technology has the potential to treat genetic disorders, combat infectious diseases, and possibly eradicate some inherited illnesses. The article provides insight into the ethical considerations and regulatory challenges accompanying such groundbreaking scientific advances.

Summarizing the article, Smith (2022) details how CRISPR-Cas9 has transitioned from basic research to clinical applications. Scientists are now exploring its ability to correct mutations responsible for diseases like cystic fibrosis, sickle cell anemia, and certain cancers. The article showcases ongoing clinical trials and the optimism surrounding these approaches while also emphasizing concerns about unintended genetic consequences and ethical issues, including potential misuse for non-therapeutic enhancements. The author emphasizes that, although promising, CRISPR technologies require careful regulation to ensure safety and ethical integrity.

This article closely relates to the concepts covered in this biology course, particularly genetics, molecular biology, and biotechnology. The course has provided foundational knowledge of DNA structure, gene expression, and genetic inheritance, which are essential for understanding the mechanisms of gene editing.

The principles of cellular function, mutation, and DNA repair processes discussed in class underpin the scientific basis for CRISPR technology. Additionally, the ethical considerations introduced in our coursework are echoed in the debates surrounding the regulation and misuse of gene editing tools, emphasizing the importance of responsible scientific practice.

The course text, such as Campbell and Reece’s Biology (2020), offers comprehensive background on genetic mechanisms and biotechnology, which aids in understanding how CRISPR can be applied ethically and effectively. Concepts like genetic variation, inheritance patterns, and cellular control systems provide the groundwork for appreciating both the potential and risks of gene editing technology. Without this background, the implications of CRISPR advancements might seem overly optimistic or frightening; however, the course prepares students to analyze these issues critically. Thus, this course enhances understanding of complex biological innovations and their societal impacts.

Personally, this article drew my attention because of its implications for medical science and the potential to alleviate suffering caused by genetic diseases. As someone with a family member affected by sickle cell anemia, I am deeply interested in breakthroughs that could improve quality of life or provide cures. Scientifically, I recognize that gene editing could offer revolutionary treatments, but I am also aware of the ethical dilemmas involved, such as potential modifications in germline cells that could be inherited by future generations. The possibility of designer babies and genetic discrimination raises questions about how such powerful technology should be governed, making this topic highly relevant to my concerns about medical ethics and societal equity.

Regarding research funding, I believe that public investment plays a crucial role in the responsible development of gene editing technologies. Taxpayer funding should support research that aligns with societal values and public health priorities, including equitable access and safety assessments. Private sector funding is also important, as it can accelerate innovation and commercialization. However, without adequate oversight and ethical guidelines, private interests may prioritize profit over safety and social benefit. Therefore, a balanced approach involving both public and private funding with strict regulation is essential. Comparing the importance of CRISPR research to other scientific fields, I consider it a high priority because of its potential to address significant health issues and its capacity for ethical controversy. Investing in responsible research on gene editing can lead to substantial societal benefits, provided that ethical concerns are carefully managed.

References

Campbell, N. A., & Reece, J. B. (2020). Biology (12th ed.). Pearson. Smith, J. (2022). CRISPR Gene Editing: The Future of Medicine. The New York Times.

Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 337(6096), 816–821.

Doudna, J. A., & Charpentier, E. (2014). The new frontier of genome engineering with CRISPR-Cas9. Science, 346(6213), 1258096.

Hsu, P. D., Lander, E. S., & Zhang, F. (2014). Development and applications of CRISPR-Cas9 for genome engineering. Cell, 157(6), 1262–1278.

Lander, E. S. (2019). The ethics of gene editing. Nature, 568(7753), 141–142.

National Institutes of Health. (2021). Ethical considerations in genome editing. NIH. https://www.nih.gov/

Ormond, K. E., et al. (2017). Human gene editing research and regulation. Nature Reviews Genetics, 18(7), 397–410.

Haeussler, M., et al. (2016). Evaluation of off-target and on-target effects of CRISPR-Cas9 genome editing. Nature Biotechnology, 34(7), 808–816.

National Academies of Sciences, Engineering, and Medicine. (2017). Human genome editing: Science, ethics, and governance. The National Academies Press.

Turn static files into dynamic content formats.

Create a flipbook
Select one (1) article from a magazine or newspaper that has by Dr Jack Online - Issuu